Verve Therapeutics
VERV
#7339
Rank
NZ$0.58 B
Marketcap
$6.63
Share price
-1.66%
Change (1 day)
-52.44%
Change (1 year)

P/S ratio for Verve Therapeutics (VERV)

P/S ratio as of April 2025 (TTM): 10.4

According to Verve Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.6794. At the end of 2024 the company had a P/S ratio of 15.8.

P/S ratio history for Verve Therapeutics from 2021 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202415.8-83.47%
202395.3-84.47%
2022614
2021N/A